DSS
DSS, INC.
+0.02 (+2.02%)0.76USD20.6K成交股數7.6M市值–本益比(近四季)0.4股價營收比-31.8%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 3.6M-32% | 4.3M-13% | 4.1M-26% | 6.4M+52% | 5.3M+37% | 5.0M+91% | 5.6M+34% | 4.2M-42% | 3.9M | 2.6M | 4.2M | 7.2M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 2.9M | 4.3M | 2.0M | 3.6M | 3.2M | 3.5M | 3.7M | 3.5M | 3.6M | 30.3M | 3.2M | 8.9M |
| 營業利益 | −3.8M+11% | −5.5M+47% | −4.0M-13% | −3.2M-34% | −3.4M-27% | −3.7M-89% | −4.7M-8% | −4.9M-23% | −4.7M | −33.6M | −5.1M | −6.5M |
| 營業利益率 | -105.0% | -126.7% | -98.1% | -50.6% | -64.8% | -75.2% | -83.4% | -117.2% | -120.9% | -1,298.0% | -122.0% | -89.2% |
| 稅後淨利 | −4.8M+123% | −5.8M+22% | −14.8M+180% | −2.2M-52% | −2.2M-47% | −4.8M-54% | −5.3M+22% | −4.7M-88% | −4.1M | −10.3M | −4.3M | −37.9M |
| 淨利率 | -132.9% | -134.4% | -358.0% | -34.9% | -40.7% | -96.4% | -94.4% | -111.2% | -105.2% | -398.4% | -103.8% | -524.3% |
| 稀釋 EPS | – | – | – | – | – | – | -0.75+21% | -0.66-88% | -0.58 | -1.01 | -0.62 | -5.41 |
| 稀釋股數 | 10.0M | 9.6M | 9.0M | 9.1M | 9.1M | 8.7M | 7.1M | 7.1M | 7.1M | 7.0M | 7.0M | 7.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 4.1M | 4.9M | 6.2M | 7.0M | 9.4M | 10.8M | 11.6M | 10.7M | 9.3M | 6.6M | 6.9M | 10.0M |
| 應收帳款 | 1.3M | 2.0M | 2.3M | 4.1M | 2.7M | 2.6M | 2.7M | 2.5M | 2.9M | 4.0M | 3.1M | 2.5M |
| 存貨 | 2.0M | 1.8M | 2.0M | 2.9M | 2.5M | 2.5M | 3.3M | 3.6M | 3.6M | 2.8M | 3.9M | 5.3M |
| 總資產 | 68.4M | 71.3M | 67.6M | 92.1M | 93.4M | 92.4M | 143M | 144M | 149M | 153M | 197M | 205M |
| 有息負債 | 5.3M | 5.5M | 5.7M | 6.0M | 6.2M | 2.4M | 7.4M | 7.0M | 7.4M | 7.5M | 7.7M | 7.2M |
| 總負債 | 59.9M | 58.7M | 58.9M | 66.0M | 66.0M | 62.6M | 73.0M | – | – | 70.0M | – | – |
| 股東權益 | −382K | 3.4M | −832K | 14.2M | 15.7M | 17.9M | 52.1M | 55.2M | 59.9M | 63.9M | 94.3M | 98.6M |
| 負債比 | 87.6% | 82.4% | 87.1% | 71.7% | 70.7% | 67.7% | 51.2% | – | – | 45.7% | – | – |
| 淨現金(現金 − 有息負債) | −1.2M | −560K | 487K | 1.1M | 3.2M | 8.4M | 4.2M | 3.7M | 1.8M | −836K | −850K | 2.8M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −133K-179% | – | – | – | 168K | – | – | −2.2M | – | – | – |
| 資本支出 | – | – | – | – | – | 52K | – | – | 3K | 138K | 67K | 19K |
| 自由現金流 | – | – | – | – | – | 116K | – | – | −2.2M | – | – | – |
| 折舊攤銷 | – | 633K | – | – | – | 523K | – | – | 582K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | 2.3% | – | – | -55.6% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 23.4M
| Product Packaging | 18.2M | 77.7% | +12.7% |
|---|---|---|---|
| Securities | 2.5M | 10.8% | -8.7% |
| Securities Revenue Information | 2.5M | 10.8% | -8.7% |
| Commercial Banking | 45K | 0.2% | -80.1% |
| Commercial Lending Revenue Information | 45K | 0.2% | -80.1% |
| Biotechnology | 38K | 0.2% | – |
| Biotechnology Revenue Information | 38K | 0.2% | – |
產品／服務2025 年度 · 20.8M
| Printed Products | 18.1M | 87.1% | +12.3% |
|---|---|---|---|
| Commission | 1.4M | 6.5% | +39.2% |
| Rental Income | 1.2M | 6.0% | -31.0% |
| Commercial Lending | 45K | 0.2% | -80.1% |
| Biotechnology | 38K | 0.2% | – |
| Printed Products Revenue Information 小計 | 18.2M | 87.4% | +12.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 20.8M | +8.7% | −23.9M | -115.3% | – | – |
| FY2024 | 19.1M | -26.4% | −46.9M | -245.6% | -6.63 | −8.9M |
| FY2023 | 25.9M | -8.6% | −60.6M | -233.8% | -8.20 | −20.0M |
| FY2022 | 28.4M | +40.0% | −59.8M | -210.8% | -6.84 | −28.8M |
| FY2021 | 20.3M | +31.9% | −33.1M | -163.3% | -0.68 | −23.3M |
| FY2020 | 15.4M | -1.2% | 1.9M | 12.4% | 0.03 | −7.2M |
| FY2019 | 15.6M | -16.0% | −2.9M | -18.6% | -0.11 | −6.3M |
| FY2018 | 18.5M | – | 1.5M | 7.9% | 0.09 | −2.4M |